Andere talen Eterna Therapeutics Inc.

Aandelen

ERNA

US1140822099

Beurs gesloten - Nasdaq Andere beurzen 22:30:01 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,78 ^USD	+0,56%		-9,18%	-0,84%

14/03	Eterna Therapeutics Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
20/02	Eterna Therapeutics Inc. Kondigt de benoeming aan van Peter Cicala, JD tot lid van de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

North American Morning Briefing : Inflation -2-	15/03
Eterna Therapeutics Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Eterna Therapeutics Announces the Appointment of Peter Cicala, JD, to its Board of Directors	20/02
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala, JD to Its Board of Directors	20/02
Eterna Therapeutics Inc. Announces Appointment of Peter Cicala to the Board of the Audit Committee, the Compensation Committee and the Nominating and Corporate Governance Committee	16/02
Eterna Therapeutics Inc. Announces Management Changes	19/01
Eterna Therapeutics Grants New President and CEO Sanjeev Luther Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)	03/01
Eterna Therapeutics Inc Announces Chief Executive Officer Changes, Effective January 1, 2024	21/12
Eterna Therapeutics Inc Appoints Sanjeev Luther as President and Member of the Board of Directors, Effective January 1, 2024	21/12
Eterna Therapeutics Inc. Appoints James Bristol as Chairman of the Board	20/12
Eterna Therapeutics Names Sanjeev Luther as President and Chief Executive Officer	20/12
Eterna Therapeutics Selling $9.2 Million of Convertible Promissory Notes, Accompanying Warrants	15/12
Eterna Therapeutics Announces $9.2 Million Convertible Debt and Warrant Financing	15/12
Eterna Therapeutics Inc. announced that it expects to receive $9.2 million in funding	14/12
Eterna Therapeutics Inc. announced that it has received $1.5 million in funding	08/12
Eterna Therapeutics Inc. Enter into an Exclusive Amended and Restated License Agreement with Factor Bioscience Limited	16/11
Eterna Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	13/11
Eterna Therapeutics Inc. Appoints James Bristol to Its Board of Directors	01/11
Eterna Therapeutics Appoints James Bristol, Ph.D., Pharmaceutical Research and Drug Discovery Veteran, to Board of Directors	01/11
Calidi Biotherapeutics Names Andrew Jackson as Chief Financial Officer	30-10-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Eterna Therapeutics Inc.

Aandelen

ERNA

US1140822099

Andere talen

Filters